These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 16033330)

  • 1. Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.
    Skirgello OE; Binevski PV; Pozdnev VF; Kost OA
    Biochem J; 2005 Nov; 391(Pt 3):641-7. PubMed ID: 16033330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.
    Binevski PV; Sizova EA; Pozdnev VF; Kost OA
    FEBS Lett; 2003 Aug; 550(1-3):84-8. PubMed ID: 12935891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
    Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
    Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface plasmon resonance analysis of the binding mechanism of pharmacological and peptidic inhibitors to human somatic angiotensin I-converting enzyme.
    Zidane F; Zeder-Lutz G; Altschuh D; Girardet JM; Miclo L; Corbier C; Cakir-Kiefer C
    Biochemistry; 2013 Dec; 52(48):8722-31. PubMed ID: 24168709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural determinants of RXPA380, a potent and highly selective inhibitor of the angiotensin-converting enzyme C-domain.
    Georgiadis D; Cuniasse P; Cotton J; Yiotakis A; Dive V
    Biochemistry; 2004 Jun; 43(25):8048-54. PubMed ID: 15209500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.
    Natesh R; Schwager SL; Sturrock ED; Acharya KR
    Nature; 2003 Jan; 421(6922):551-4. PubMed ID: 12540854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A calorimetric study of the binding of lisinopril, enalaprilat and captopril to angiotensin-converting enzyme.
    Andújar-Sánchez M; Cámara-Artigas A; Jara-Pérez V
    Biophys Chem; 2004 Oct; 111(2):183-9. PubMed ID: 15381315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory antibodies to human angiotensin-converting enzyme: fine epitope mapping and mechanism of action.
    Skirgello OE; Balyasnikova IV; Binevski PV; Sun ZL; Baskin II; Palyulin VA; Nesterovitch AB; Albrecht RF; Kost OA; Danilov SM
    Biochemistry; 2006 Apr; 45(15):4831-47. PubMed ID: 16605251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
    Udupa EG; Rao NM
    Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme.
    Jullien ND; Cuniasse P; Georgiadis D; Yiotakis A; Dive V
    FEBS J; 2006 Apr; 273(8):1772-81. PubMed ID: 16623712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of a lipophilic captopril analogue binding to angiotensin I converting enzyme.
    Dalkas GA; Marchand D; Galleyrand JC; Martinez J; Spyroulias GA; Cordopatis P; Cavelier F
    J Pept Sci; 2010 Feb; 16(2):91-7. PubMed ID: 20014331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin I-converting enzyme transition state stabilization by HIS1089: evidence for a catalytic mechanism distinct from other gluzincin metalloproteinases.
    Fernandez M; Liu X; Wouters MA; Heyberger S; Husain A
    J Biol Chem; 2001 Feb; 276(7):4998-5004. PubMed ID: 11067854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors.
    Wei L; Clauser E; Alhenc-Gelas F; Corvol P
    J Biol Chem; 1992 Jul; 267(19):13398-405. PubMed ID: 1320019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous determination of ACE activity with 2 substrates provides information on the status of somatic ACE and allows detection of inhibitors in human blood.
    Danilov SM; Balyasnikova IV; Albrecht RF; Kost OA
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):90-103. PubMed ID: 18645413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal structure of the N domain of human somatic angiotensin I-converting enzyme provides a structural basis for domain-specific inhibitor design.
    Corradi HR; Schwager SL; Nchinda AT; Sturrock ED; Acharya KR
    J Mol Biol; 2006 Mar; 357(3):964-74. PubMed ID: 16476442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of bovine atrial angiotensin-converting enzyme.
    Garats EV; Nikolskaya II; Binevski PV; Pozdnev VF; Kost OA
    Biochemistry (Mosc); 2001 Apr; 66(4):429-34. PubMed ID: 11403651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates.
    Bersanetti PA; Andrade MC; Casarini DE; Juliano MA; Nchinda AT; Sturrock ED; Juliano L; Carmona AK
    Biochemistry; 2004 Dec; 43(50):15729-36. PubMed ID: 15595828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural details on the binding of antihypertensive drugs captopril and enalaprilat to human testicular angiotensin I-converting enzyme.
    Natesh R; Schwager SL; Evans HR; Sturrock ED; Acharya KR
    Biochemistry; 2004 Jul; 43(27):8718-24. PubMed ID: 15236580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of domain-selective angiotensin I-converting enzyme inhibitors.
    Redelinghuys P; Nchinda AT; Sturrock ED
    Ann N Y Acad Sci; 2005 Nov; 1056():160-75. PubMed ID: 16387685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simulated interactions between angiotensin-converting enzyme and substrate gonadotropin-releasing hormone: novel insights into domain selectivity.
    Papakyriakou A; Spyroulias GA; Sturrock ED; Manessi-Zoupa E; Cordopatis P
    Biochemistry; 2007 Jul; 46(30):8753-65. PubMed ID: 17605472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.